Revolutionary advancement in patient-specific orthopedic solutions now available through Bodycad’s website. FDA Cleared. Patent Pending.
Bodycad is pleased to announce the official release of its FDA cleared TTO (Tibial Tubercle Osteotomy) system. This milestone represents a significant advancement in Bodycad’s mission to deliver personalized, data-driven orthopedic solutions that enhance surgical precision and support patient care.
The TTO system has received regulatory approval following rigorous evaluation, underscoring its safety and performance, and alignment with the highest industry standards. Designed with patient-specific anatomy at its core, the system integrates advanced imaging, surgical planning, and custom manufacturing to help surgeons address complex knee pathologies with greater confidence and accuracy.
The addition of the TTO system to Bodycad’s digital platform provides healthcare professionals with streamlined access to detailed product information, clinical resources, and workflow integration tools. The website experience has been enhanced to facilitate intuitive navigation, allowing surgeons and partners to efficiently explore the system’s capabilities and incorporate it into their clinical practice.
“This launch marks an important step forward in expanding our portfolio of personalized orthopedic solutions,” said Geoffroy Rivet-Sabourin, CEO at Bodycad. “By bringing the TTO system to our website, we are making it easier for surgeons to access innovative tools that are tailored to each patient’s unique anatomy, ultimately improving surgical outcomes and patient satisfaction.”
The TTO system complements Bodycad’s existing suite of patient-specific solutions and reinforces the company’s commitment to innovation, precision, and collaboration with the medical community.
For more information about the TTO system and to explore its features, please visit: bodycad.com/fine-tto/
Contact
Steve Pruitt (404 307-9974)
Bodycad USA Inc.
5935 Barclay Lane
Naples, FL 34110
info@bodycad.com
